nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—ALB—Estropipate—osteoporosis	0.151	0.245	CbGbCtD
Oxcarbazepine—ALB—Estradiol—osteoporosis	0.0626	0.102	CbGbCtD
Oxcarbazepine—CYP2C19—Cholecalciferol—osteoporosis	0.0503	0.0818	CbGbCtD
Oxcarbazepine—CYP3A5—Estradiol—osteoporosis	0.0503	0.0818	CbGbCtD
Oxcarbazepine—CYP3A4—Estropipate—osteoporosis	0.0472	0.0768	CbGbCtD
Oxcarbazepine—CYP3A4—Calcitriol—osteoporosis	0.0472	0.0768	CbGbCtD
Oxcarbazepine—CYP2C19—Estradiol—osteoporosis	0.0406	0.066	CbGbCtD
Oxcarbazepine—CYP3A4—Ergocalciferol—osteoporosis	0.0378	0.0614	CbGbCtD
Oxcarbazepine—CYP3A4—Raloxifene—osteoporosis	0.0315	0.0512	CbGbCtD
Oxcarbazepine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0304	0.0495	CbGbCtD
Oxcarbazepine—CYP3A4—Cholecalciferol—osteoporosis	0.0243	0.0396	CbGbCtD
Oxcarbazepine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0223	0.0363	CbGbCtD
Oxcarbazepine—CYP3A4—Estradiol—osteoporosis	0.0196	0.0319	CbGbCtD
Oxcarbazepine—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000868	0.0554	CbGpPWpGaD
Oxcarbazepine—Indapamide—CA2—osteoporosis	0.00082	1	CrCbGaD
Oxcarbazepine—SCN5A—Cardiac Progenitor Differentiation—DKK1—osteoporosis	0.00047	0.03	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—WDR1—osteoporosis	0.000323	0.0206	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	0.000307	0.0196	CbGpPWpGaD
Oxcarbazepine—ALB—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.000307	0.0196	CbGpPWpGaD
Oxcarbazepine—ALB—Lipoprotein metabolism—P4HB—osteoporosis	0.000302	0.0193	CbGpPWpGaD
Oxcarbazepine—ALB—Lipid and lipoprotein metabolism—MGLL—osteoporosis	0.000295	0.0189	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—CAP1—osteoporosis	0.000255	0.0163	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000248	0.0158	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	0.000243	0.0155	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000237	0.0151	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000234	0.0149	CbGpPWpGaD
Oxcarbazepine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A2—osteoporosis	0.000231	0.0147	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—CAP1—osteoporosis	0.000221	0.0141	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.00021	0.0134	CbGpPWpGaD
Oxcarbazepine—ALB—Lipid and lipoprotein metabolism—P4HB—osteoporosis	0.000201	0.0128	CbGpPWpGaD
Oxcarbazepine—Asthenia—Alendronate—osteoporosis	0.000193	0.000523	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Ibandronate—osteoporosis	0.000193	0.000523	CcSEcCtD
Oxcarbazepine—Cough—Conjugated Estrogens—osteoporosis	0.000193	0.000523	CcSEcCtD
Oxcarbazepine—Dyspnoea—Risedronate—osteoporosis	0.000192	0.000522	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Estradiol—osteoporosis	0.000192	0.000521	CcSEcCtD
Oxcarbazepine—CYP3A5—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000192	0.0123	CbGpPWpGaD
Oxcarbazepine—Hypotension—Pamidronate—osteoporosis	0.000192	0.00052	CcSEcCtD
Oxcarbazepine—Convulsion—Conjugated Estrogens—osteoporosis	0.000191	0.000519	CcSEcCtD
Oxcarbazepine—Dry mouth—Zoledronate—osteoporosis	0.000191	0.000518	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000191	0.000518	CcSEcCtD
Oxcarbazepine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000191	0.000517	CcSEcCtD
Oxcarbazepine—Pruritus—Alendronate—osteoporosis	0.00019	0.000516	CcSEcCtD
Oxcarbazepine—Dyspepsia—Risedronate—osteoporosis	0.00019	0.000515	CcSEcCtD
Oxcarbazepine—Eye disorder—Estradiol—osteoporosis	0.00019	0.000515	CcSEcCtD
Oxcarbazepine—Tinnitus—Estradiol—osteoporosis	0.000189	0.000514	CcSEcCtD
Oxcarbazepine—Constipation—Ethinyl Estradiol—osteoporosis	0.000189	0.000513	CcSEcCtD
Oxcarbazepine—Confusional state—Zoledronate—osteoporosis	0.000189	0.000512	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Calcitriol—osteoporosis	0.000189	0.000512	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Estradiol—osteoporosis	0.000189	0.000511	CcSEcCtD
Oxcarbazepine—Flushing—Estradiol—osteoporosis	0.000189	0.000511	CcSEcCtD
Oxcarbazepine—Chest pain—Conjugated Estrogens—osteoporosis	0.000188	0.00051	CcSEcCtD
Oxcarbazepine—Myalgia—Conjugated Estrogens—osteoporosis	0.000188	0.00051	CcSEcCtD
Oxcarbazepine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000188	0.00051	CcSEcCtD
Oxcarbazepine—Asthenia—Ibandronate—osteoporosis	0.000188	0.000509	CcSEcCtD
Oxcarbazepine—Anxiety—Conjugated Estrogens—osteoporosis	0.000188	0.000509	CcSEcCtD
Oxcarbazepine—Nausea—Etidronic acid—osteoporosis	0.000187	0.000508	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Zoledronate—osteoporosis	0.000187	0.000508	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000187	0.000507	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000187	0.000507	CcSEcCtD
Oxcarbazepine—Diarrhoea—Estropipate—osteoporosis	0.000187	0.000507	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000186	0.000505	CcSEcCtD
Oxcarbazepine—Infection—Zoledronate—osteoporosis	0.000186	0.000505	CcSEcCtD
Oxcarbazepine—Fatigue—Risedronate—osteoporosis	0.000186	0.000504	CcSEcCtD
Oxcarbazepine—Insomnia—Pamidronate—osteoporosis	0.000185	0.000503	CcSEcCtD
Oxcarbazepine—ALB—Platelet degranulation—PLEK—osteoporosis	0.000185	0.0118	CbGpPWpGaD
Oxcarbazepine—Pruritus—Ibandronate—osteoporosis	0.000185	0.000502	CcSEcCtD
Oxcarbazepine—Constipation—Risedronate—osteoporosis	0.000184	0.0005	CcSEcCtD
Oxcarbazepine—Pain—Risedronate—osteoporosis	0.000184	0.0005	CcSEcCtD
Oxcarbazepine—Angiopathy—Estradiol—osteoporosis	0.000184	0.0005	CcSEcCtD
Oxcarbazepine—Shock—Zoledronate—osteoporosis	0.000184	0.0005	CcSEcCtD
Oxcarbazepine—Diarrhoea—Alendronate—osteoporosis	0.000184	0.000499	CcSEcCtD
Oxcarbazepine—Asthenia—Calcitriol—osteoporosis	0.000184	0.000499	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Zoledronate—osteoporosis	0.000184	0.000498	CcSEcCtD
Oxcarbazepine—Immune system disorder—Estradiol—osteoporosis	0.000184	0.000498	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Zoledronate—osteoporosis	0.000183	0.000497	CcSEcCtD
Oxcarbazepine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000183	0.0117	CbGpPWpGaD
Oxcarbazepine—Dyspnoea—Pamidronate—osteoporosis	0.000183	0.000496	CcSEcCtD
Oxcarbazepine—Tachycardia—Zoledronate—osteoporosis	0.000183	0.000496	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000182	0.000495	CcSEcCtD
Oxcarbazepine—Chills—Estradiol—osteoporosis	0.000182	0.000494	CcSEcCtD
Oxcarbazepine—Somnolence—Pamidronate—osteoporosis	0.000182	0.000494	CcSEcCtD
Oxcarbazepine—Skin disorder—Zoledronate—osteoporosis	0.000182	0.000493	CcSEcCtD
Oxcarbazepine—SCN5A—Cardiac Progenitor Differentiation—IGF1—osteoporosis	0.000181	0.0116	CbGpPWpGaD
Oxcarbazepine—Pruritus—Calcitriol—osteoporosis	0.000181	0.000492	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Zoledronate—osteoporosis	0.000181	0.000491	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000181	0.000491	CcSEcCtD
Oxcarbazepine—Diarrhoea—Raloxifene—osteoporosis	0.000181	0.000491	CcSEcCtD
Oxcarbazepine—CYP2C19—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000181	0.0115	CbGpPWpGaD
Oxcarbazepine—Dyspepsia—Pamidronate—osteoporosis	0.000181	0.00049	CcSEcCtD
Oxcarbazepine—Dizziness—Estropipate—osteoporosis	0.000181	0.00049	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00018	0.000489	CcSEcCtD
Oxcarbazepine—Alopecia—Estradiol—osteoporosis	0.00018	0.000487	CcSEcCtD
Oxcarbazepine—Infection—Conjugated Estrogens—osteoporosis	0.000179	0.000486	CcSEcCtD
Oxcarbazepine—Diarrhoea—Ibandronate—osteoporosis	0.000179	0.000486	CcSEcCtD
Oxcarbazepine—Anorexia—Zoledronate—osteoporosis	0.000179	0.000484	CcSEcCtD
Oxcarbazepine—Decreased appetite—Pamidronate—osteoporosis	0.000178	0.000484	CcSEcCtD
Oxcarbazepine—Mental disorder—Estradiol—osteoporosis	0.000178	0.000483	CcSEcCtD
Oxcarbazepine—Dizziness—Alendronate—osteoporosis	0.000178	0.000482	CcSEcCtD
Oxcarbazepine—Shock—Conjugated Estrogens—osteoporosis	0.000177	0.000481	CcSEcCtD
Oxcarbazepine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—osteoporosis	0.000177	0.0113	CbGpPWpGaD
Oxcarbazepine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000177	0.00048	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000177	0.00048	CcSEcCtD
Oxcarbazepine—Malnutrition—Estradiol—osteoporosis	0.000177	0.00048	CcSEcCtD
Oxcarbazepine—Fatigue—Pamidronate—osteoporosis	0.000177	0.00048	CcSEcCtD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.000177	0.0113	CbGpPWpGaD
Oxcarbazepine—Gastrointestinal pain—Risedronate—osteoporosis	0.000176	0.000478	CcSEcCtD
Oxcarbazepine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000176	0.000477	CcSEcCtD
Oxcarbazepine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000176	0.000477	CcSEcCtD
Oxcarbazepine—Pain—Pamidronate—osteoporosis	0.000175	0.000476	CcSEcCtD
Oxcarbazepine—Constipation—Pamidronate—osteoporosis	0.000175	0.000476	CcSEcCtD
Oxcarbazepine—Diarrhoea—Calcitriol—osteoporosis	0.000175	0.000476	CcSEcCtD
Oxcarbazepine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000175	0.000475	CcSEcCtD
Oxcarbazepine—Hypotension—Zoledronate—osteoporosis	0.000175	0.000475	CcSEcCtD
Oxcarbazepine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000175	0.000474	CcSEcCtD
Oxcarbazepine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000175	0.000474	CcSEcCtD
Oxcarbazepine—Dizziness—Raloxifene—osteoporosis	0.000175	0.000474	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000174	0.000473	CcSEcCtD
Oxcarbazepine—Flatulence—Estradiol—osteoporosis	0.000174	0.000473	CcSEcCtD
Oxcarbazepine—Tension—Estradiol—osteoporosis	0.000174	0.000471	CcSEcCtD
Oxcarbazepine—Vomiting—Estropipate—osteoporosis	0.000174	0.000471	CcSEcCtD
Oxcarbazepine—Dysgeusia—Estradiol—osteoporosis	0.000173	0.00047	CcSEcCtD
Oxcarbazepine—Dizziness—Ibandronate—osteoporosis	0.000173	0.000469	CcSEcCtD
Oxcarbazepine—Rash—Estropipate—osteoporosis	0.000172	0.000467	CcSEcCtD
Oxcarbazepine—Dermatitis—Estropipate—osteoporosis	0.000172	0.000466	CcSEcCtD
Oxcarbazepine—Anorexia—Conjugated Estrogens—osteoporosis	0.000172	0.000466	CcSEcCtD
Oxcarbazepine—Nervousness—Estradiol—osteoporosis	0.000172	0.000466	CcSEcCtD
Oxcarbazepine—Urticaria—Risedronate—osteoporosis	0.000171	0.000465	CcSEcCtD
Oxcarbazepine—Back pain—Estradiol—osteoporosis	0.000171	0.000464	CcSEcCtD
Oxcarbazepine—Headache—Estropipate—osteoporosis	0.000171	0.000464	CcSEcCtD
Oxcarbazepine—Vomiting—Alendronate—osteoporosis	0.000171	0.000464	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000171	0.000463	CcSEcCtD
Oxcarbazepine—Abdominal pain—Risedronate—osteoporosis	0.000171	0.000463	CcSEcCtD
Oxcarbazepine—Body temperature increased—Risedronate—osteoporosis	0.000171	0.000463	CcSEcCtD
Oxcarbazepine—Rash—Alendronate—osteoporosis	0.00017	0.00046	CcSEcCtD
Oxcarbazepine—Insomnia—Zoledronate—osteoporosis	0.000169	0.00046	CcSEcCtD
Oxcarbazepine—Dermatitis—Alendronate—osteoporosis	0.000169	0.000459	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Pamidronate—osteoporosis	0.000169	0.000458	CcSEcCtD
Oxcarbazepine—Hypotension—Conjugated Estrogens—osteoporosis	0.000169	0.000457	CcSEcCtD
Oxcarbazepine—Headache—Alendronate—osteoporosis	0.000168	0.000457	CcSEcCtD
Oxcarbazepine—Vomiting—Raloxifene—osteoporosis	0.000168	0.000456	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000168	0.000455	CcSEcCtD
Oxcarbazepine—Dyspnoea—Zoledronate—osteoporosis	0.000167	0.000453	CcSEcCtD
Oxcarbazepine—Rash—Raloxifene—osteoporosis	0.000167	0.000452	CcSEcCtD
Oxcarbazepine—Dermatitis—Raloxifene—osteoporosis	0.000167	0.000452	CcSEcCtD
Oxcarbazepine—Somnolence—Zoledronate—osteoporosis	0.000167	0.000452	CcSEcCtD
Oxcarbazepine—Vomiting—Ibandronate—osteoporosis	0.000166	0.000451	CcSEcCtD
Oxcarbazepine—Tremor—Estradiol—osteoporosis	0.000166	0.000449	CcSEcCtD
Oxcarbazepine—Headache—Raloxifene—osteoporosis	0.000166	0.000449	CcSEcCtD
Oxcarbazepine—Rash—Ibandronate—osteoporosis	0.000165	0.000448	CcSEcCtD
Oxcarbazepine—Dermatitis—Ibandronate—osteoporosis	0.000165	0.000447	CcSEcCtD
Oxcarbazepine—Dyspepsia—Zoledronate—osteoporosis	0.000165	0.000447	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000164	0.000446	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Estradiol—osteoporosis	0.000164	0.000445	CcSEcCtD
Oxcarbazepine—Headache—Ibandronate—osteoporosis	0.000164	0.000445	CcSEcCtD
Oxcarbazepine—Insomnia—Conjugated Estrogens—osteoporosis	0.000163	0.000442	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000163	0.000442	CcSEcCtD
Oxcarbazepine—Vomiting—Calcitriol—osteoporosis	0.000163	0.000442	CcSEcCtD
Oxcarbazepine—Decreased appetite—Zoledronate—osteoporosis	0.000163	0.000442	CcSEcCtD
Oxcarbazepine—Agitation—Estradiol—osteoporosis	0.000163	0.000441	CcSEcCtD
Oxcarbazepine—Nausea—Estropipate—osteoporosis	0.000162	0.00044	CcSEcCtD
Oxcarbazepine—Body temperature increased—Pamidronate—osteoporosis	0.000162	0.00044	CcSEcCtD
Oxcarbazepine—Abdominal pain—Pamidronate—osteoporosis	0.000162	0.00044	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000162	0.000439	CcSEcCtD
Oxcarbazepine—Angioedema—Estradiol—osteoporosis	0.000162	0.000438	CcSEcCtD
Oxcarbazepine—Rash—Calcitriol—osteoporosis	0.000162	0.000438	CcSEcCtD
Oxcarbazepine—Fatigue—Zoledronate—osteoporosis	0.000162	0.000438	CcSEcCtD
Oxcarbazepine—Dermatitis—Calcitriol—osteoporosis	0.000161	0.000438	CcSEcCtD
Oxcarbazepine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000161	0.000436	CcSEcCtD
Oxcarbazepine—Headache—Calcitriol—osteoporosis	0.000161	0.000435	CcSEcCtD
Oxcarbazepine—Somnolence—Conjugated Estrogens—osteoporosis	0.00016	0.000435	CcSEcCtD
Oxcarbazepine—Pain—Zoledronate—osteoporosis	0.00016	0.000434	CcSEcCtD
Oxcarbazepine—Constipation—Zoledronate—osteoporosis	0.00016	0.000434	CcSEcCtD
Oxcarbazepine—ALB—Platelet degranulation—TLN1—osteoporosis	0.00016	0.0102	CbGpPWpGaD
Oxcarbazepine—Nausea—Alendronate—osteoporosis	0.00016	0.000433	CcSEcCtD
Oxcarbazepine—Malaise—Estradiol—osteoporosis	0.00016	0.000433	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Risedronate—osteoporosis	0.000159	0.000431	CcSEcCtD
Oxcarbazepine—Vertigo—Estradiol—osteoporosis	0.000159	0.000431	CcSEcCtD
Oxcarbazepine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000159	0.000431	CcSEcCtD
Oxcarbazepine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000159	0.000431	CcSEcCtD
Oxcarbazepine—Syncope—Estradiol—osteoporosis	0.000159	0.00043	CcSEcCtD
Oxcarbazepine—SCN5A—Developmental Biology—CAP1—osteoporosis	0.000158	0.0101	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—VCL—osteoporosis	0.000158	0.0101	CbGpPWpGaD
Oxcarbazepine—Nausea—Raloxifene—osteoporosis	0.000157	0.000426	CcSEcCtD
Oxcarbazepine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000157	0.000425	CcSEcCtD
Oxcarbazepine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000157	0.000425	CcSEcCtD
Oxcarbazepine—Palpitations—Estradiol—osteoporosis	0.000156	0.000424	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000156	0.000422	CcSEcCtD
Oxcarbazepine—Fatigue—Conjugated Estrogens—osteoporosis	0.000156	0.000422	CcSEcCtD
Oxcarbazepine—Nausea—Ibandronate—osteoporosis	0.000155	0.000422	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Estradiol—osteoporosis	0.000155	0.000422	CcSEcCtD
Oxcarbazepine—Asthenia—Risedronate—osteoporosis	0.000155	0.00042	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Zoledronate—osteoporosis	0.000154	0.000419	CcSEcCtD
Oxcarbazepine—Cough—Estradiol—osteoporosis	0.000154	0.000419	CcSEcCtD
Oxcarbazepine—Constipation—Conjugated Estrogens—osteoporosis	0.000154	0.000418	CcSEcCtD
Oxcarbazepine—Pain—Conjugated Estrogens—osteoporosis	0.000154	0.000418	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000153	0.000415	CcSEcCtD
Oxcarbazepine—Hypertension—Estradiol—osteoporosis	0.000153	0.000414	CcSEcCtD
Oxcarbazepine—Pruritus—Risedronate—osteoporosis	0.000153	0.000414	CcSEcCtD
Oxcarbazepine—Nausea—Calcitriol—osteoporosis	0.000152	0.000413	CcSEcCtD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.000152	0.00972	CbGpPWpGaD
Oxcarbazepine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000151	0.000411	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Pamidronate—osteoporosis	0.000151	0.00041	CcSEcCtD
Oxcarbazepine—Arthralgia—Estradiol—osteoporosis	0.000151	0.000408	CcSEcCtD
Oxcarbazepine—Chest pain—Estradiol—osteoporosis	0.000151	0.000408	CcSEcCtD
Oxcarbazepine—Myalgia—Estradiol—osteoporosis	0.000151	0.000408	CcSEcCtD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.00015	0.00959	CbGpPWpGaD
Oxcarbazepine—Anxiety—Estradiol—osteoporosis	0.00015	0.000407	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00015	0.000406	CcSEcCtD
Oxcarbazepine—Urticaria—Zoledronate—osteoporosis	0.000149	0.000404	CcSEcCtD
Oxcarbazepine—Discomfort—Estradiol—osteoporosis	0.000149	0.000404	CcSEcCtD
Oxcarbazepine—CYP2C19—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000148	0.00948	CbGpPWpGaD
Oxcarbazepine—Abdominal pain—Zoledronate—osteoporosis	0.000148	0.000402	CcSEcCtD
Oxcarbazepine—Body temperature increased—Zoledronate—osteoporosis	0.000148	0.000402	CcSEcCtD
Oxcarbazepine—Diarrhoea—Risedronate—osteoporosis	0.000148	0.0004	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000147	0.0004	CcSEcCtD
Oxcarbazepine—Dry mouth—Estradiol—osteoporosis	0.000147	0.000399	CcSEcCtD
Oxcarbazepine—Asthenia—Pamidronate—osteoporosis	0.000147	0.000399	CcSEcCtD
Oxcarbazepine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000146	0.000397	CcSEcCtD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000146	0.00931	CbGpPWpGaD
Oxcarbazepine—Confusional state—Estradiol—osteoporosis	0.000146	0.000395	CcSEcCtD
Oxcarbazepine—Pruritus—Pamidronate—osteoporosis	0.000145	0.000394	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Estradiol—osteoporosis	0.000144	0.000392	CcSEcCtD
Oxcarbazepine—Infection—Estradiol—osteoporosis	0.000143	0.000389	CcSEcCtD
Oxcarbazepine—Urticaria—Conjugated Estrogens—osteoporosis	0.000143	0.000389	CcSEcCtD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.000143	0.00915	CbGpPWpGaD
Oxcarbazepine—Dizziness—Risedronate—osteoporosis	0.000143	0.000387	CcSEcCtD
Oxcarbazepine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000143	0.000387	CcSEcCtD
Oxcarbazepine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000143	0.000387	CcSEcCtD
Oxcarbazepine—Shock—Estradiol—osteoporosis	0.000142	0.000385	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Estradiol—osteoporosis	0.000142	0.000384	CcSEcCtD
Oxcarbazepine—Tachycardia—Estradiol—osteoporosis	0.000141	0.000382	CcSEcCtD
Oxcarbazepine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000141	0.000382	CcSEcCtD
Oxcarbazepine—Diarrhoea—Pamidronate—osteoporosis	0.00014	0.000381	CcSEcCtD
Oxcarbazepine—Skin disorder—Estradiol—osteoporosis	0.00014	0.00038	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Estradiol—osteoporosis	0.00014	0.000379	CcSEcCtD
Oxcarbazepine—Rash—Ethinyl Estradiol—osteoporosis	0.00014	0.000378	CcSEcCtD
Oxcarbazepine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000139	0.000378	CcSEcCtD
Oxcarbazepine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000139	0.00886	CbGpPWpGaD
Oxcarbazepine—Headache—Ethinyl Estradiol—osteoporosis	0.000139	0.000376	CcSEcCtD
Oxcarbazepine—SCN5A—Axon guidance—TLN1—osteoporosis	0.000138	0.00884	CbGpPWpGaD
Oxcarbazepine—Hypersensitivity—Zoledronate—osteoporosis	0.000138	0.000374	CcSEcCtD
Oxcarbazepine—Vomiting—Risedronate—osteoporosis	0.000137	0.000372	CcSEcCtD
Oxcarbazepine—SCN5A—Axon guidance—ACTG1—osteoporosis	0.000136	0.00872	CbGpPWpGaD
Oxcarbazepine—Rash—Risedronate—osteoporosis	0.000136	0.000369	CcSEcCtD
Oxcarbazepine—Dermatitis—Risedronate—osteoporosis	0.000136	0.000369	CcSEcCtD
Oxcarbazepine—Dizziness—Pamidronate—osteoporosis	0.000136	0.000368	CcSEcCtD
Oxcarbazepine—Headache—Risedronate—osteoporosis	0.000135	0.000367	CcSEcCtD
Oxcarbazepine—Asthenia—Zoledronate—osteoporosis	0.000134	0.000365	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000133	0.00036	CcSEcCtD
Oxcarbazepine—Pruritus—Zoledronate—osteoporosis	0.000133	0.000359	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000132	0.000357	CcSEcCtD
Oxcarbazepine—Nausea—Ethinyl Estradiol—osteoporosis	0.000131	0.000356	CcSEcCtD
Oxcarbazepine—Insomnia—Estradiol—osteoporosis	0.000131	0.000354	CcSEcCtD
Oxcarbazepine—Vomiting—Pamidronate—osteoporosis	0.00013	0.000354	CcSEcCtD
Oxcarbazepine—Asthenia—Conjugated Estrogens—osteoporosis	0.000129	0.000351	CcSEcCtD
Oxcarbazepine—Rash—Pamidronate—osteoporosis	0.000129	0.000351	CcSEcCtD
Oxcarbazepine—Dermatitis—Pamidronate—osteoporosis	0.000129	0.00035	CcSEcCtD
Oxcarbazepine—Dyspnoea—Estradiol—osteoporosis	0.000129	0.000349	CcSEcCtD
Oxcarbazepine—Headache—Pamidronate—osteoporosis	0.000128	0.000348	CcSEcCtD
Oxcarbazepine—Somnolence—Estradiol—osteoporosis	0.000128	0.000348	CcSEcCtD
Oxcarbazepine—Diarrhoea—Zoledronate—osteoporosis	0.000128	0.000348	CcSEcCtD
Oxcarbazepine—Nausea—Risedronate—osteoporosis	0.000128	0.000348	CcSEcCtD
Oxcarbazepine—Pruritus—Conjugated Estrogens—osteoporosis	0.000128	0.000346	CcSEcCtD
Oxcarbazepine—Dyspepsia—Estradiol—osteoporosis	0.000127	0.000345	CcSEcCtD
Oxcarbazepine—Decreased appetite—Estradiol—osteoporosis	0.000125	0.00034	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000125	0.000338	CcSEcCtD
Oxcarbazepine—Fatigue—Estradiol—osteoporosis	0.000124	0.000338	CcSEcCtD
Oxcarbazepine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000124	0.00795	CbGpPWpGaD
Oxcarbazepine—Dizziness—Zoledronate—osteoporosis	0.000124	0.000336	CcSEcCtD
Oxcarbazepine—Constipation—Estradiol—osteoporosis	0.000123	0.000335	CcSEcCtD
Oxcarbazepine—Pain—Estradiol—osteoporosis	0.000123	0.000335	CcSEcCtD
Oxcarbazepine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000123	0.000335	CcSEcCtD
Oxcarbazepine—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000123	0.00784	CbGpPWpGaD
Oxcarbazepine—Nausea—Pamidronate—osteoporosis	0.000122	0.00033	CcSEcCtD
Oxcarbazepine—ALB—Platelet degranulation—FGA—osteoporosis	0.000119	0.00763	CbGpPWpGaD
Oxcarbazepine—Dizziness—Conjugated Estrogens—osteoporosis	0.000119	0.000324	CcSEcCtD
Oxcarbazepine—Vomiting—Zoledronate—osteoporosis	0.000119	0.000323	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Estradiol—osteoporosis	0.000119	0.000323	CcSEcCtD
Oxcarbazepine—Rash—Zoledronate—osteoporosis	0.000118	0.00032	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Estradiol—osteoporosis	0.000118	0.00032	CcSEcCtD
Oxcarbazepine—Dermatitis—Zoledronate—osteoporosis	0.000118	0.00032	CcSEcCtD
Oxcarbazepine—Headache—Zoledronate—osteoporosis	0.000117	0.000318	CcSEcCtD
Oxcarbazepine—Vomiting—Conjugated Estrogens—osteoporosis	0.000115	0.000311	CcSEcCtD
Oxcarbazepine—Urticaria—Estradiol—osteoporosis	0.000115	0.000311	CcSEcCtD
Oxcarbazepine—Abdominal pain—Estradiol—osteoporosis	0.000114	0.00031	CcSEcCtD
Oxcarbazepine—Body temperature increased—Estradiol—osteoporosis	0.000114	0.00031	CcSEcCtD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.000114	0.00727	CbGpPWpGaD
Oxcarbazepine—Rash—Conjugated Estrogens—osteoporosis	0.000114	0.000308	CcSEcCtD
Oxcarbazepine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000114	0.000308	CcSEcCtD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000113	0.00723	CbGpPWpGaD
Oxcarbazepine—Headache—Conjugated Estrogens—osteoporosis	0.000113	0.000306	CcSEcCtD
Oxcarbazepine—Nausea—Zoledronate—osteoporosis	0.000111	0.000302	CcSEcCtD
Oxcarbazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.00011	0.00703	CbGpPWpGaD
Oxcarbazepine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—osteoporosis	0.000109	0.00695	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—FGB—osteoporosis	0.000109	0.00694	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000109	0.00694	CbGpPWpGaD
Oxcarbazepine—Nausea—Conjugated Estrogens—osteoporosis	0.000107	0.000291	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Estradiol—osteoporosis	0.000106	0.000288	CcSEcCtD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—SOD2—osteoporosis	0.000104	0.00665	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000104	0.00663	CbGpPWpGaD
Oxcarbazepine—Asthenia—Estradiol—osteoporosis	0.000104	0.000281	CcSEcCtD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.000104	0.00661	CbGpPWpGaD
Oxcarbazepine—Pruritus—Estradiol—osteoporosis	0.000102	0.000277	CcSEcCtD
Oxcarbazepine—CYP3A5—Biological oxidations—CYP27A1—osteoporosis	0.000102	0.00652	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000101	0.00644	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—CYP27A1—osteoporosis	0.000101	0.00643	CbGpPWpGaD
Oxcarbazepine—Diarrhoea—Estradiol—osteoporosis	9.88e-05	0.000268	CcSEcCtD
Oxcarbazepine—SCN5A—Developmental Biology—TLN1—osteoporosis	9.87e-05	0.00631	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—ACTG1—osteoporosis	9.74e-05	0.00622	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	9.62e-05	0.00614	CbGpPWpGaD
Oxcarbazepine—Dizziness—Estradiol—osteoporosis	9.55e-05	0.000259	CcSEcCtD
Oxcarbazepine—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	9.49e-05	0.00606	CbGpPWpGaD
Oxcarbazepine—Vomiting—Estradiol—osteoporosis	9.18e-05	0.000249	CcSEcCtD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—MTHFR—osteoporosis	9.17e-05	0.00586	CbGpPWpGaD
Oxcarbazepine—Rash—Estradiol—osteoporosis	9.1e-05	0.000247	CcSEcCtD
Oxcarbazepine—Dermatitis—Estradiol—osteoporosis	9.09e-05	0.000247	CcSEcCtD
Oxcarbazepine—CYP2C19—Arachidonic acid metabolism—GPX1—osteoporosis	9.06e-05	0.00579	CbGpPWpGaD
Oxcarbazepine—Headache—Estradiol—osteoporosis	9.04e-05	0.000245	CcSEcCtD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	8.99e-05	0.00574	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	8.92e-05	0.0057	CbGpPWpGaD
Oxcarbazepine—Nausea—Estradiol—osteoporosis	8.58e-05	0.000233	CcSEcCtD
Oxcarbazepine—ALB—Folate Metabolism—SOD2—osteoporosis	8.47e-05	0.00541	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	8.22e-05	0.00525	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—GPX1—osteoporosis	8.08e-05	0.00516	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	7.96e-05	0.00509	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—CYP27A1—osteoporosis	7.88e-05	0.00504	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	7.8e-05	0.00498	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—CYP27A1—osteoporosis	7.77e-05	0.00497	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—IL6R—osteoporosis	7.75e-05	0.00495	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—WNT1—osteoporosis	7.59e-05	0.00485	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.48e-05	0.00478	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—MTHFR—osteoporosis	7.46e-05	0.00477	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—WDR1—osteoporosis	7.38e-05	0.00471	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	7.15e-05	0.00457	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	7.09e-05	0.00453	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	6.99e-05	0.00447	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	6.73e-05	0.0043	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	6.42e-05	0.0041	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.06e-05	0.00387	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	5.93e-05	0.00379	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—IL1B—osteoporosis	5.9e-05	0.00377	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	5.87e-05	0.00375	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	5.84e-05	0.00373	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—CAP1—osteoporosis	5.83e-05	0.00373	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	5.78e-05	0.00369	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.78e-05	0.00369	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	5.71e-05	0.00365	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	5.57e-05	0.00356	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	5.44e-05	0.00348	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	5.36e-05	0.00342	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	5.3e-05	0.00338	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	5.28e-05	0.00338	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	5.27e-05	0.00337	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	5e-05	0.00319	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—IGF1—osteoporosis	4.92e-05	0.00314	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	4.82e-05	0.00308	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	4.74e-05	0.00303	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.69e-05	0.003	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	4.69e-05	0.00299	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.69e-05	0.00299	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	4.68e-05	0.00299	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—MGLL—osteoporosis	4.63e-05	0.00296	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—IL1B—osteoporosis	4.43e-05	0.00283	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	4.33e-05	0.00277	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—IL6R—osteoporosis	4.32e-05	0.00276	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—TNF—osteoporosis	4.28e-05	0.00273	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—ANXA2—osteoporosis	4.24e-05	0.00271	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PLEK—osteoporosis	4.24e-05	0.00271	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	4.22e-05	0.0027	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	4.14e-05	0.00265	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	4.08e-05	0.00261	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	3.95e-05	0.00252	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.89e-05	0.00248	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.79e-05	0.00242	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—LEP—osteoporosis	3.68e-05	0.00235	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	3.67e-05	0.00234	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—TLN1—osteoporosis	3.65e-05	0.00233	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—VCL—osteoporosis	3.6e-05	0.0023	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	3.52e-05	0.00225	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.48e-05	0.00222	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—IL6—osteoporosis	3.45e-05	0.00221	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.37e-05	0.00215	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—POMC—osteoporosis	3.22e-05	0.00206	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—TNF—osteoporosis	3.21e-05	0.00205	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	3.19e-05	0.00204	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—IL6R—osteoporosis	3.08e-05	0.00197	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—FDPS—osteoporosis	3.04e-05	0.00194	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PKM—osteoporosis	3.04e-05	0.00194	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	3.03e-05	0.00193	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—RAP1A—osteoporosis	3.01e-05	0.00192	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—TGFB1—osteoporosis	2.95e-05	0.00188	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PGLS—osteoporosis	2.88e-05	0.00184	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GPD2—osteoporosis	2.88e-05	0.00184	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.87e-05	0.00183	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.82e-05	0.0018	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	2.81e-05	0.0018	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—FGA—osteoporosis	2.73e-05	0.00174	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ATIC—osteoporosis	2.63e-05	0.00168	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PNP—osteoporosis	2.63e-05	0.00168	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PKM—osteoporosis	2.61e-05	0.00167	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—FDPS—osteoporosis	2.61e-05	0.00167	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—IL6—osteoporosis	2.59e-05	0.00166	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.57e-05	0.00164	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—TNF—osteoporosis	2.55e-05	0.00163	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.49e-05	0.00159	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—POMC—osteoporosis	2.49e-05	0.00159	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—FGB—osteoporosis	2.48e-05	0.00159	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PGLS—osteoporosis	2.48e-05	0.00158	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GPD2—osteoporosis	2.48e-05	0.00158	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.46e-05	0.00157	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PKM—osteoporosis	2.35e-05	0.0015	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—FDPS—osteoporosis	2.35e-05	0.0015	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PNP—osteoporosis	2.27e-05	0.00145	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ATIC—osteoporosis	2.27e-05	0.00145	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CA2—osteoporosis	2.24e-05	0.00143	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—OXCT1—osteoporosis	2.24e-05	0.00143	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PGLS—osteoporosis	2.23e-05	0.00142	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GPD2—osteoporosis	2.23e-05	0.00142	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	2.18e-05	0.00139	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—MGLL—osteoporosis	2.18e-05	0.00139	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—IL6—osteoporosis	2.06e-05	0.00132	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ATIC—osteoporosis	2.04e-05	0.0013	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PNP—osteoporosis	2.04e-05	0.0013	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—OXCT1—osteoporosis	1.93e-05	0.00123	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CA2—osteoporosis	1.93e-05	0.00123	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—IL6—osteoporosis	1.92e-05	0.00123	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—MGLL—osteoporosis	1.88e-05	0.0012	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—IDH2—osteoporosis	1.85e-05	0.00119	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—TGFB1—osteoporosis	1.82e-05	0.00116	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.77e-05	0.00113	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP27A1—osteoporosis	1.74e-05	0.00111	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—OXCT1—osteoporosis	1.73e-05	0.00111	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CA2—osteoporosis	1.73e-05	0.00111	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—TNF—osteoporosis	1.7e-05	0.00109	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ACP5—osteoporosis	1.7e-05	0.00108	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—MGLL—osteoporosis	1.69e-05	0.00108	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—IDH2—osteoporosis	1.6e-05	0.00102	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.59e-05	0.00102	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—TPI1—osteoporosis	1.58e-05	0.00101	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP27A1—osteoporosis	1.5e-05	0.00096	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—POMC—osteoporosis	1.5e-05	0.000956	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—P4HB—osteoporosis	1.48e-05	0.000947	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ACP5—osteoporosis	1.46e-05	0.000933	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GAPDH—osteoporosis	1.46e-05	0.00093	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.44e-05	0.000922	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—IDH2—osteoporosis	1.43e-05	0.000916	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—RAP1A—osteoporosis	1.42e-05	0.000906	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PKM—osteoporosis	1.41e-05	0.000902	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—FDPS—osteoporosis	1.41e-05	0.000902	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.38e-05	0.000879	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—IL6—osteoporosis	1.37e-05	0.000877	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—TPI1—osteoporosis	1.36e-05	0.000868	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.35e-05	0.000861	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PGLS—osteoporosis	1.34e-05	0.000855	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GPD2—osteoporosis	1.34e-05	0.000855	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ACP5—osteoporosis	1.31e-05	0.000838	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.31e-05	0.000836	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.29e-05	0.000827	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—P4HB—osteoporosis	1.28e-05	0.000816	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GAPDH—osteoporosis	1.25e-05	0.000801	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ATIC—osteoporosis	1.22e-05	0.000782	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PNP—osteoporosis	1.22e-05	0.000782	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—RAP1A—osteoporosis	1.22e-05	0.00078	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—TPI1—osteoporosis	1.22e-05	0.000779	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—P4HB—osteoporosis	1.15e-05	0.000732	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ENO1—osteoporosis	1.15e-05	0.000732	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PSMA2—osteoporosis	1.13e-05	0.000721	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PSMA5—osteoporosis	1.13e-05	0.000721	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GAPDH—osteoporosis	1.13e-05	0.000719	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IGF1—osteoporosis	1.12e-05	0.000719	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—RAP1A—osteoporosis	1.1e-05	0.0007	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.06e-05	0.00068	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—OXCT1—osteoporosis	1.04e-05	0.000665	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CA2—osteoporosis	1.04e-05	0.000665	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—MGLL—osteoporosis	1.01e-05	0.000648	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ENO1—osteoporosis	9.87e-06	0.000631	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PSMA2—osteoporosis	9.72e-06	0.000621	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PSMA5—osteoporosis	9.72e-06	0.000621	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.56e-06	0.000611	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP19A1—osteoporosis	9.16e-06	0.000585	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ENO1—osteoporosis	8.86e-06	0.000566	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PSMA5—osteoporosis	8.73e-06	0.000558	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PSMA2—osteoporosis	8.73e-06	0.000558	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—IDH2—osteoporosis	8.62e-06	0.000551	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP27A1—osteoporosis	8.11e-06	0.000518	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP19A1—osteoporosis	7.89e-06	0.000504	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ACP5—osteoporosis	7.89e-06	0.000504	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ADCY5—osteoporosis	7.48e-06	0.000478	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GPX1—osteoporosis	7.46e-06	0.000477	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—TPI1—osteoporosis	7.33e-06	0.000468	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP19A1—osteoporosis	7.08e-06	0.000452	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—P4HB—osteoporosis	6.89e-06	0.00044	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—MTHFR—osteoporosis	6.88e-06	0.00044	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GAPDH—osteoporosis	6.77e-06	0.000432	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—TGFB1—osteoporosis	6.74e-06	0.000431	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—RAP1A—osteoporosis	6.59e-06	0.000421	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ADCY5—osteoporosis	6.45e-06	0.000412	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GPX1—osteoporosis	6.42e-06	0.00041	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—MTHFR—osteoporosis	5.93e-06	0.000379	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ADCY5—osteoporosis	5.79e-06	0.00037	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GPX1—osteoporosis	5.77e-06	0.000368	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—POMC—osteoporosis	5.51e-06	0.000352	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ENO1—osteoporosis	5.33e-06	0.00034	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—MTHFR—osteoporosis	5.32e-06	0.00034	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PSMA2—osteoporosis	5.25e-06	0.000335	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PSMA5—osteoporosis	5.25e-06	0.000335	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—POMC—osteoporosis	4.74e-06	0.000303	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.26e-06	0.000272	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—POMC—osteoporosis	4.26e-06	0.000272	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ADCY5—osteoporosis	3.48e-06	0.000222	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GPX1—osteoporosis	3.47e-06	0.000222	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—MTHFR—osteoporosis	3.2e-06	0.000204	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—POMC—osteoporosis	2.56e-06	0.000164	CbGpPWpGaD
